Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Jun 09  •  04:00PM ET
25.74
Dollar change
+0.15
Percentage change
0.58
%
Category
Global or ExUS Equities - Industry Sector
Asset Type
Equities (Stocks)
Tags
Return% 1Y
-
Total Holdings
56
Perf Week
3.73%
Sponsor
Portfolio Building Block
ETF Type
Tags
Return% 3Y
-
AUM
801.54M
Perf Month
4.05%
Fund Family
Bond Type
Tags
Return% 5Y
-
NAV/sh
Perf Quarter
-1.53%
Index
BITA Global Pharma and Biotech Sel Indx
Average Maturity
Tags
Return% 10Y
52W High
27.47 -6.30%
Perf Half Y
4.39%
Index Weighting
Commodity Type
Tags
Return% SI
52W Low
24.18 6.43%
Perf YTD
1.96%
Active/Passive
Quant Type
Tags
-
Flows% 1M
3.25%
Volatility
1.14% 1.06%
Perf Year
-
ESG Type
Tags
-
Flows% 3M
19.21%
ATR (14)
0.34
Perf 3Y
-
Dividend Type
Sector/Theme
Flows% YTD
-
RSI (14)
56.06
Perf 5Y
-
Structure Type
Region
Flows% 1Y
Beta
-
Perf 10Y
-
Expense
0.13%
Growth/Value
SMA20
1.47%
Flows% 3Y
Rel Volume
0.81
Prev Close
25.59
Inverse/Leveraged
Market Cap
SMA50
1.81%
Flows% 5Y
Avg Volume
91.80K
Price
25.74
IPO
Nov 25, 2025
Option/Short
No / Yes
SMA200
0.55%
Trades
Volume
75,033
Change
0.58%
Jun-09-26 08:48PM
Portfolio Building Block World Pharma And Biotech Index ETF seeks to track the performance, before fees and expenses, of the BITA Global Pharma and Biotech Select Index. The fund uses a "passive management" approach to track the performance, before fees and expenses, of the index. The index is constructed using a rules-based methodology that identifies companies in the pharmaceutical and/or biotechnology industries with publicly traded ordinary shares listed on major stock exchanges in developed markets, as classified by BITA GmbH. Under normal circumstances, the fund will invest at least 80% of the fund's net assets in component securities that make up the index. The fund is non-diversified.